Clinical Trials Directory

Trials / Completed

CompletedNCT02926352

Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training

Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training in the Modification of Pathological Fear

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
112 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

There are two specific aims for this study. Aim 1 is to test whether low-level laser therapy (LLLT) can enhance the efficacy of fear extinction training in the modification of pathological fear. Aim 2 is to investigate the efficacy of low-level laser therapy (LLLT) as a stand-alone intervention for anxiety/phobias.

Detailed description

Preliminary research with non-human animals suggests that LLLT (i.e., ultra low doses of transcranial infrared light) can enhance the retention of fear extinction learning by up regulating neuronal metabolic activity when applied to the ventromedial prefrontal cortex (vmPFC). Furthermore, evidence from a previous uncontrolled trial with humans suggests that LLLT (outside the context of extinction training) can lead to a significant decrease in symptoms of depression and anxiety when applied to the right and left dorsolateral prefrontal cortices (dlPFC). The first aim of this study is to test whether LLLT can boost fear reduction after extinction training in humans. A second aim of this study is to investigate the efficacy of LLLT as a stand-alone anxiolytic intervention in a randomized controlled trial. Individuals between the ages of 18-65 with elevated fear in any of one of four domains (e.g., fear of enclosed spaces, fear of contamination, fear of public speaking, or anxiety sensitivity) are randomly assigned to one of four treatment arms (1) Extinction Training with LLLT, (2) Extinction Training with Sham LLLT, (3) LLLT alone, or (4) Sham LLLT alone. To determine eligibility, all participants undergo an online prescreen and a face-to-face screening assessment. Participants who qualify for the study then complete a baseline (pre-treatment) assessment, followed immediately by the treatment procedure and a post-treatment assessment. Participants return to the lab an average of 14 days after treatment to complete a follow-up assessment. Participants complete two behavioral approach tests (in the treatment context and in the generalization context) at baseline, post-treatment, and follow-up, and a battery of self-report questionnaires at baseline and follow-up.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExtinction TrainingUp to 40 min. of self-directed repeated exposure to a fear-provoking situation.
DEVICELow-Level Laser Therapy1064nm light used to modulate a biological function and induce a therapeutic effect.
DEVICESham Low-Level Laser TherapyPlacebo dose version of LLLT.

Timeline

Start date
2015-08-01
Primary completion
2020-05-04
Completion
2020-05-04
First posted
2016-10-06
Last updated
2022-12-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02926352. Inclusion in this directory is not an endorsement.